Showing results (41-50 of 424) with videos related to
Sort By:
Pageof 43
Trends in Cancer|December 9, 2022
Impact of tissue-agnostic approvals for patients with gastrointestinal malignanciesDeepak Bhamidipati, Vivek SubbiahTrends in Cancer|July 30, 2023
Tumor-agnostic drug development in dMMR/MSI-H solid tumorsDeepak Bhamidipati, Vivek SubbiahTargeted Oncology|May 13, 2026
HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding PatientsVivek Subbiah, Martin DietrichCell Reports. Medicine|December 20, 2023
Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancersMirella Nardo, Mohamed A Gouda, Blessie E Nelson, et al.Cancer Discovery|April 4, 2022
Think Globally, Act Locally: Globalizing Precision OncologyJustin T Moyers, Vivek SubbiahCancer Discovery|February 26, 2020
Advances in Targeting RET-Dependent CancersVivek Subbiah, Gilbert J CoteCancer Discovery|December 4, 2019
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway InhibitionVivek Subbiah, Sumanta K PalCarcinogenesis|November 8, 2024
Redefining pancreatic cancer management with tumor-agnostic precision medicineNeha K Reddy, Vivek SubbiahSaudi Medical Journal|June 10, 2016
Student research in Arab world. What is the current state?Omar A Aboshady, Mohamed A GoudaMed (New York, N.Y.)|November 11, 2023
Selinexor: Changing the paradigm in patients with TP53 wild-type endometrial cancer?Mohamed A Gouda, Kyaw Z TheinPageof 43